Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation

NCT00380250 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

590

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Constipation

Interventions

DRUG: Lubiprostone
DRUG: Placebo

Sponsor

Sucampo Pharma Americas, LLC

Collaborators

[object Object]